Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart

Overexpression of the human epidermal growth factor receptor 2 (HER2) in breast and gastric cancer is exploited for targeted therapy using monoclonal antibodies and antibody-drug conjugates. Small engineered scaffold proteins, such as the albumin binding domain (ABD) derived affinity proteins (ADAPT...

Descripción completa

Detalles Bibliográficos
Autores principales: Garousi, Javad, Xu, Tianqi, Liu, Yongsheng, Vorontsova, Olga, Hober, Sophia, Orlova, Anna, Tolmachev, Vladimir, Gräslund, Torbjörn, Vorobyeva, Anzhelika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415843/
https://www.ncbi.nlm.nih.gov/pubmed/36015242
http://dx.doi.org/10.3390/pharmaceutics14081612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415843/
https://www.ncbi.nlm.nih.gov/pubmed/36015242
http://dx.doi.org/10.3390/pharmaceutics14081612

Ejemplares similares